Physician profile
Edmond Bedrossian
NPI 1508988106
$3,712,335.43
in general payments reported to CMS, 2019-2025
7 companies · $503K in 2025
The $503K reported for 2025 was more than what 99% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $354K · 2020: $629K · 2021: $559K · 2022: $503K · 2023: $474K · 2024: $690K · 2025: $503K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $934K · Honoraria: $673K · Travel and Lodging: $55K · Food and Beverage: $4,846 · Entertainment: $444 · Gift: $232 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $65.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $933,640.81 |
| Honoraria | $672,595.38 |
| Travel and Lodging | $55,032.91 |
| Food and Beverage | $4,846.09 |
| Entertainment | $443.56 |
| Gift | $231.94 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $65.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $3,711,410.52 | 2019-2025 | |
| Keystone Dental INC. | $579.98 | 2019-2023 | |
| Geistlich Pharma, North America, INC. | $170.19 | 2024 | Geistlich Bio-Gide |
| Depuy Synthes Sales INC. | $75.48 | 2020 | |
| Septodont INC. | $37.34 | 2024 | Orasoothe Sockit Gel Syringe |
| Stryker Corporation | $36.92 | 2023 | Na |
| Nobel Biocare USA | $25.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edmond Bedrossian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.